NEOG NEOGEN CORP
FY2025 10-K
NEOGEN CORP (NEOG) filed its fiscal year 2025 10-K annual report with the SEC on Jul 30, 2025. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.
AI Filing AnalysisFY2025 10-K
Business Overview
- • Core business model: Develops, manufactures, and markets diagnostic test kits and complementary products for food and animal safety globally
- • New emphasis: Completion of 3M Food Safety Division acquisition Sept 2022, now a wholly owned subsidiary, expanding Food Safety segment portfolio
Management Discussion & Analysis
- • Revenue $894.7M, down 3% YoY from $924.2M, decline driven by $24.3M FX headwind and $3.9M discontinued product lines
- • Gross margin 47.1% vs 50.2% YoY, decrease due to lower volume, higher manufacturing costs, inventory write-offs, tariffs, and $4.4M restructuring charges
Risk Factors
- • Foreign exchange risk reducing revenue by $44.9M from 10% USD depreciation, impacting 50.2% of international revenues in fiscal year 2025
- • Interest rate risk with 38.9% of total debt at variable rates, causing $2.6M earnings loss from 75 basis point rate increase
Financial SummaryXBRL
Revenue
$895M
Net Income
-$1.1B
Gross Margin
47.1%
Operating Margin
-118.6%
Net Margin
-122.1%
ROE
-52.7%
Total Assets
$3.4B
EPS (Diluted)
$-5.03
Operating Cash Flow
$58M
Source: XBRL data from NEOGEN CORP FY2025 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on NEOGEN CORP
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.